Effects of irbesartan on the growth and differentiation of adipocytes in obese Zucker rats

Obesity Research

Volumn 13, Issue 11, 2005, Pages 1909-1914

  Di Filippo, Clara ^a,b   Lampa, Enrico ^a,b   Tufariello, Elisabetta ^a   Petronella, Pasquale ^b   Freda, Fulvio ^b   Capuano, Annalisa ^a,b   D'Amico, Michele ^a,b  

^a Department of Experimental Medicine   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Adipocytes; Differentiation; Irbesartan; Zucker rats

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BIPHENYL DERIVATIVE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; IRBESARTAN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TETRAZOLE DERIVATIVE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; ZUCKER RAT;

ADIPOCYTES; ADIPOSE TISSUE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GLYCEROLPHOSPHATE DEHYDROGENASE; IMMUNOHISTOCHEMISTRY; LEPTIN; OBESITY; PPAR GAMMA; RATS; RATS, ZUCKER; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; TETRAZOLES;

EID: 33644832968     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.235     Document Type: Article

References (33)

1. Nakajima M, Hutchinson HG, Fujinaga M, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA. 1995;92:10663-7.
2. Ailhaud G, Fukamizu A, Massiera F, Negrel R, Saint-Marc P, Teboul M. Angiotensinogen, angiotensin II and adipose tissue development. Int J Obes Relat Metab Disord. 2000;24:S33-5.
3. Engeli S, Schling P, Gorzelniak K, et al. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol. 2003;35:807-25.
4. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension. 2000;35:1270-7.
5. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens. 2002;20:965-73.
6. Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M. Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension. 2001; 38:884-90.
7. Shimamura T, Masui M, Toril M, Nakajima M. Hypotensive and prophylactic effects of angiotensin II subtype 1 receptor antagonist, irbesartan, in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens. 2004;26:27-42.
8. Cassis LA, English VL, Bharadwaj K, Boutstany CM. Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. Endocrinology. 2004;145:169-74.
9. Gorla-Bajszczak A, Siegrist-Kaiser C, Boss O, Burger AG, Meier CA. Expression of peroxisome proliferator-activated receptors in lean and obese Zucker rats. Eur J Endocrinol. 2000;142:71-8.
10. Vegusdal A, Sundvold H, Gjonen T, Ruyter B. An in vitro method for studying the proliferation and differentiation of Atlantic salmon preadipocytes. Lipids. 2003;38:289-96.
11. Wise, LS, Green H. Participation of one isoenzyme of cytosolic glycerophosphate dehydrogenase in adipose conversion of 3T3 cells. J Biol Chem. 1979;254:273-5.
12. Abraham G, Simon G. Autopotentiation of pressor responses by subpressor angiotensin II in rats. Am J Hypertens. 1994;7: 269-75.
13. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: rate of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;68:905-21.
14. Brink M, SeUen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest. 1996;97:2509-16.
15. Campbell DJ, Duncan AM, Kladis A. Measurements of angiotensin peptides. Hypertension. 1995;26:843-5.
16. Campfield LA, Smith FJ, Guisez Y, Devos R, Bum P. Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995;269:546-9.
17. Cassis L, Fettinger M, Roe A, Shenoy U, Howard G. Characterization and regulation of angiotensin II receptor in rat adipose tissue. In: Raizada M, ed. Recent Advances in Cellular and Molecular Aspects of Angiotensin Receptors. New York: Plenum; 1996, pp. 39-47.
18. Cassis LA, Dwoskin LP. Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue2E J Neural Transm. 1991;34:129-37.
19. Cassis LA, Saye JA, Peach MJ. Location and regulation of rat angiotensinogen messenger RNA. Hypertension. 1988;11: 591-6.
20. Chai SY. Localization of components of the renin-angiotensin system and site of action of inhibitors. Azeneimittelforschung. 1993;43:214-21.
21. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature. 1996;380: 677.
22. Diz DI, Baer PG, Nasjletti A. Angiotensin II-induced hypertension in the rat: effects on the plasma concentrations, renal excretion, and tissue release of prostaglandins. J Clin Invest. 1983;72:466-77.
23. Dzau VJ. Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens. 1994;12:S3-10.
24. Griffin S, Brown W, MacPherson F, et al. Angiotensin 11 causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991;17:626-35.
25. Hiramatsu K, Yamada T, Ichidawa K, Izumiyama T, Nagata H. Changes in endocrine activities relative to obesity in patients with essential hypertension. J Am Geriatr Soc: 1981;29:25-30.
26. Heo YR, Claycombe K, Wright P, et al. Effects of fatty (fa) allele and high-fat diet on adipose tissue leptin and lipid metabolism. Horm Metab Res. 2002;34:686-90.
27. Sharma AM. Is there a rationale for ungiotensin blockade in the management of obesity hypertension? Hypertension. 2004;44:12-9.
28. Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3t3-L1 and human adipose cells. Endocrinology. 1997;138:1512-9.
29. Darimont C, Vassaux G, Ailhaud G, Negrel R. Differentiationof preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology. 1994;135:2030-6.
30. Schling P, Loffler G. Angiotensin II receptors during differentiation of human preadipocytes. Int J Obes Relat Metab Disord. 1998;22:899.
31. Juan CC, Chien Y, Wu LY, et al. Angiotensin II enhances insulin sensitivity in vitro and in vivo. Endocrinology. 2005;146:2246-54.
32. Mallow H, Trindl A, Loffler G. Production of angiotensin II receptors type 1 (ATI) and type 2 (AT2) during the differentiation of 3T3-L1 preadipocytes in culture. Eating Weight Disord. 1999;4:41.
33. Crandall DL, Herlinger HE, Saunders BD, Kral JG. Developmental aspects of the adipose tissue renin-angiotensin system: therapeutic implications. Drugs Dev Res. 1994;32: 117-25.